FDA Drug Application (076194) for LISINOPRIL AND HYDROCHLOROTHIAZIDE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number076194
Product Number001
FormTABLET;ORAL
Dosage12.5MG;20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLISINOPRIL AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; LISINOPRIL

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient LISINOPRIL7


Back to FDA Applications sponsored by WATSON LABS